Novel manganese (II) complex based on EDTA coordination cage bearing benzothiazole aniline (BTA) moiety with high chelation stability was designed and synthesized for use as a liver-specific MRI contrast agent. In addition to forming a hydrophilic, this new hepatobiliary Mn(II) chelate is rapidly taken up by hepatocyte of liver. The magnetic and kinetic properties of Mn(II) complex are higher than commercially available analogue, Mn-DPDP, which was clinically approved MR liver contrast agent. The complex, Mn-EDTA-BTA, was evaluated via in vivo MR imaging to prove high tumor detection sensitivity using animal liver tumor model.
This abstract and the presentation materials are available to members only; a login is required.